Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque Psoriasis: A phase 3 randomised non-inferiority trial

Hervé Bachelez*, Peter C.M. Van De Kerkhof, Robert Strohal, Alexey Kubanov, Fernando Valenzuela, Joo Heung Lee, Vladimir Yakusevich, Sergio Chimenti, Jocelyne Papacharalambous, James Proulx, Pankaj Gupta, Huaming Tan, Margaret Tawadrous, Hernan Valdez, Robert Wolk, Diamant Thaci

*Corresponding author for this work
130 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque Psoriasis: A phase 3 randomised non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences